Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Kamenicky

Showing results (11-20 of 58) with videos related to

Pageof 6
Sort By:
The Journal of Clinical Endocrinology and Metabolism|April 22, 2011
Body fluid expansion in acromegaly is related to enhanced epithelial sodium channel (ENaC) activityPeter Kamenicky, Anne Blanchard, Michael Frank, et al.
Journal of the Endocrine Society|December 22, 2017
Cabergoline Tapering Is Almost Always Successful in Patients With MacroprolactinomasAnne-Cécile Paepegaey, Sylvie Salenave, Peter Kamenicky, et al.
The Journal of Biological Chemistry|January 16, 2009
Reduced intestinal absorption of dipeptides via PepT1 in mice with diet-induced obesity is associated with leptin receptor down-regulationPatrick Hindlet, André Bado, Peter Kamenicky, et al.
The Journal of Clinical Endocrinology and Metabolism|September 21, 2006
McCune-Albright syndrome and acromegaly: effects of hypothalamopituitary radiotherapy and/or pegvisomant in somatostatin analog-resistant patientsFrançoise Galland, Peter Kamenicky, Hélène Affres, et al.
Endocrinology|April 5, 2008
Epithelial sodium channel is a key mediator of growth hormone-induced sodium retention in acromegalyPeter Kamenicky, Say Viengchareun, Anne Blanchard, et al.
Tissue & Cell|November 19, 2025
Microarchitecture of the cavernous sinus walls: Clinical implications for pituitary adenomasKhaled Abi Farraj, Vincent Jecko, Fanny Chasseloup, et al.
European Journal of Endocrinology|May 15, 2009
D3 GH receptor polymorphism is not associated with IGF1 levels in untreated acromegalyPeter Kamenicky, Christine Dos Santos, Consuelo Espinosa, et al.
European Journal of Endocrinology|December 24, 2025
Continuous Subcutaneous Administration of Teriparatide as a therapeutic option in Chronic Hypoparathyroidism: retrospective study in three Tertiary Care Centers of the Epi-Hypo studyAmina Attia, Mathilde Brière, Peter Kamenicky, et al.
The Journal of Clinical Endocrinology and Metabolism|May 1, 2014
Impact of successful treatment of acromegaly on overnight heart rate variability and sleep apneaDenis Chemla, Pierre Attal, Luigi Maione, et al.
European Journal of Endocrinology|October 3, 2015
Long-term effects of pegvisomant on comorbidities in patients with acromegaly: a retrospective single-center studyEmmanuelle Kuhn, Luigi Maione, Amir Bouchachi, et al.
Pageof 6

Showing results (11-20 of 58) with videos related to

Sort By:
Pageof 6
The Journal of Clinical Endocrinology and Metabolism|April 22, 2011
Body fluid expansion in acromegaly is related to enhanced epithelial sodium channel (ENaC) activityPeter Kamenicky, Anne Blanchard, Michael Frank, et al.
Journal of the Endocrine Society|December 22, 2017
Cabergoline Tapering Is Almost Always Successful in Patients With MacroprolactinomasAnne-Cécile Paepegaey, Sylvie Salenave, Peter Kamenicky, et al.
The Journal of Biological Chemistry|January 16, 2009
Reduced intestinal absorption of dipeptides via PepT1 in mice with diet-induced obesity is associated with leptin receptor down-regulationPatrick Hindlet, André Bado, Peter Kamenicky, et al.
The Journal of Clinical Endocrinology and Metabolism|September 21, 2006
McCune-Albright syndrome and acromegaly: effects of hypothalamopituitary radiotherapy and/or pegvisomant in somatostatin analog-resistant patientsFrançoise Galland, Peter Kamenicky, Hélène Affres, et al.
Endocrinology|April 5, 2008
Epithelial sodium channel is a key mediator of growth hormone-induced sodium retention in acromegalyPeter Kamenicky, Say Viengchareun, Anne Blanchard, et al.
Tissue & Cell|November 19, 2025
Microarchitecture of the cavernous sinus walls: Clinical implications for pituitary adenomasKhaled Abi Farraj, Vincent Jecko, Fanny Chasseloup, et al.
European Journal of Endocrinology|May 15, 2009
D3 GH receptor polymorphism is not associated with IGF1 levels in untreated acromegalyPeter Kamenicky, Christine Dos Santos, Consuelo Espinosa, et al.
European Journal of Endocrinology|December 24, 2025
Continuous Subcutaneous Administration of Teriparatide as a therapeutic option in Chronic Hypoparathyroidism: retrospective study in three Tertiary Care Centers of the Epi-Hypo studyAmina Attia, Mathilde Brière, Peter Kamenicky, et al.
The Journal of Clinical Endocrinology and Metabolism|May 1, 2014
Impact of successful treatment of acromegaly on overnight heart rate variability and sleep apneaDenis Chemla, Pierre Attal, Luigi Maione, et al.
European Journal of Endocrinology|October 3, 2015
Long-term effects of pegvisomant on comorbidities in patients with acromegaly: a retrospective single-center studyEmmanuelle Kuhn, Luigi Maione, Amir Bouchachi, et al.
Pageof 6